loader image
Friday, November 28, 2025
71.2 F
McAllen
- Advertisement -

How Quality Sleep Can Reduce the Risk of Heart Disease and Stroke

Translate to Spanish or other 102 languages!

Experts say a quiet and dark bedroom are two keys to getting healthy sleep every night. Image for illustration purposes
- Advertisement -
  • Researchers report that better sleep may translate into a lower risk of cardiovascular disease.
  • They add that consistent and healthy sleep patterns can improve a person’s overall well-being.
  • Experts say people having trouble sleeping should rethink pre-sleep activities and avoid stimulation before bedtime.

studyTrusted Source published in the journal JAMA Network Open reports that midlife and older adults with healthy sleep habits have a better chance of avoiding cardiovascular disease.

Follow the link Below to Medical News Today to read the full Story:

https://www.medicalnewstoday.com/articles/how-quality-sleep-can-reduce-the-risk-of-heart-disease-and-stroke?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-04-25&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral Hosting Webinar on Seasonal Depression, Dec. 4

Mega Doctor News It’s common for individuals to experience an emotional downturn during the winter...

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.
- Advertisement -
×